Quintela, D., Morgades, M., Serrano, A., Cervera, M., Balerdi, A., Díaz-Beyá, M., Arnan, M., Garrido, A., Coll, R., Tormo, M., López-Marin, J., Merchan, B., Garcia, S., Casado, M., Sampol, A., Esteve, J., Martínez-Cuadrón, D., Sierra, J., Sanz, M. Á., Ribera, J. M., Montesinos, P., & Vives, S. (n.d.). p569: GILTERITINIB AND QUIZARTINIB IN RELAPSED/REFRACTORY (R/R) ACUTE MYELOBLASTIC LEUKEMIA (AML) WITH FLT3 MUTATIONS: A REAL-LIFE EFFECTIVENESS AND SAFETY STUDY. HemaSphere, 6, 468–469. http://access.bl.uk/ark:/81055/vdc_100159756805.0x00000d